Monthly Archives: February 2012

NEW YORK--(BUSINESS WIRE)-- IntelliCell BioSciences, Inc. (OTCQB: SVFC.PK) (PINKSHEETS: SVFC.PK); (“IntelliCell”) or the (“Company”), was invited to demonstrate its stromal vascular fraction technology at the recent Baseball Injuries Symposium at the Andrews Sports Medicine Institute in Alabama held and sponsored by USA Baseball. The course Chairman is Dr. James Andrews, and moderated by PT Kevin Wilk, and Dr. Jeff Dugas. One of the courses presented during the three day event was on stem cell technology presented by Dr. Joshua Hackel. Dr. Hackel presented the state of regenerative medicine technology in the role of treating sports injuries. The link is http://www.mediafire.com/?u7bfa662e3r1sdp. Dr. Hackel compared the IntelliCell SVF technology to several other methods of regenerative medicine being considered to be used by the leading orthopedic sports medicine doctors. Dr. Steven Victor, CEO of IntelliCell stated, "We are extremely excited that IntelliCell’s technology compares very favorably to all the other technologies, for procedures common to all major sports industries. We are extremely grateful to have the opportunity to present to over 200 leading doctors and trainers looking to treat major league, collegiate and amateur baseball players with regenerative medicine. IntelliCell Biosciences believes that its technology will be utilized by such experts this year." … Continue reading →

RED BANK, NJ--(Marketwire -02/07/12)- American CryoStem Corporation (OTCQB: CRYO.OB - News) announced today that it has completed providing stem cell processing services for Personal Cell Sciences Corp., a cutting edge manufacturer of anti-aging skin care products. The study involves researching the regenerative function of a conditioned medium obtained from each participant's adipose (fat tissue) derived mesenchymal stem cells and their ability to promote the production or secretion of collagen, elastin and fibronectin related to skin wound healing. John Arnone, CEO of American CryoStem and Founder of Personal Cell Sciences, commented, "CRYO's patented tissue culture media and its proprietary, aseptic adipose tissue processing methodology allows, as an added benefit for PCS customers to store a clinical grade sample of their own stem cells for future use in regenerative medicine. We are pleased to provide comprehensive Bio-Insurance storage solutions at our clinical facility." The adipose tissue samples were acquired utilizing a mini-liposuction procedure. A total of sixty milliliters (approximately 2 fluid ounces) of adipose tissue was collected in the physician's office and sent to CRYO's laboratory for processing. Once processed, the resulting stromal vascular fraction (SVF) was forwarded to the Personal Cell Sciences laboratory for proprietary formulation for patient specific products. "We … Continue reading →

17-11-2011 08:30 Video of Holly's first step after stem cell therapy at the Stem Cell Institute in Panama. Holly suffers from periventricular leukomalacia / cerebral palsy. Read the original here: Stem Cells: Treatment for Cerebral Palsy - Video … Continue reading →

Ask any prospective parent about having a baby and they'll tell you all they want is a healthy baby.  When that doesn't happen, parents and their little one often face a lifetime of challenges.  Dr. Joanne Kurtzberg oversees the Pediatric Blood and Marrow Transplant Program at Duke University Medical Center. She aims to help these families.  She's a pioneer in cord blood stem cell therapies and currently leads a three year cord blood study to see if children with cerebral palsy can be helped. "We tested cord blood in children with cancer and genetic diseases and serendipitously learned that it also can go to the brain and correct problems in the brain. So then we had the idea that maybe cord blood from the child themselves could repair damage in the brain if the damaged occurred early in life.  And so we treated about 180 children to check and see if cord blood was safe to give to them and they did very well.  And many of the children improved but we couldn't really know if it was because of the cord blood itself,” says Dr. Joanne Kurtzberg.  The result of past stem cell therapy successes under Dr. Kurtzberg’s leadership … Continue reading →